We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
About Clickmab
Clickmab is a biotech company focused on generative AI-driven antibody design. Leveraging proprietary wet-lab data, world-leading AI antibody design algorithms, and AI agent technology, we built the Clickmab platform for efficient and precise antibody drug R&D.
Generative AI Platform for Fully Human Common-Light-Chain Antibody De Novo Design
User-specified functional antigen epitope
De novo designed antibody
Core Platform Capabilities
The platform has both de novo design and rapid optimization capabilities — using generative AI to design antibodies targeting specific epitopes from scratch.
It also enables rapid iterative optimization of known antibodies through computation + wet-lab approaches, applicable to a wide range of antibody discovery scenarios.
Core Technical Advantages
Proprietary Wet-Lab Data
Large-scale proprietary wet-lab data ensures model training accuracy and reliability
World-Leading AI Algorithms
Proprietary AI antibody design algorithms at the global frontier for precise and efficient design
AI Agent Technology
Multi-agent collaboration for fully automated antibody R&D workflows
Core Team Capabilities
An interdisciplinary elite team of AI experts, structural biologists, antibody engineers, and wet-lab scientists
AI Algorithms
Top-tier AI algorithm, protein language model, and structure prediction team.
Structural Biology
Deep understanding of biophysical principles of protein structure and function.
Antibody Engineering
Senior expertise in antibody engineering and drug development.
Wet Lab
In-house wet-lab team enabling rapid computation-experiment feedback loops.
Partner With Us
Whether you are a pharmaceutical company, biotech firm, or academic institution, we look forward to exploring collaboration opportunities